Table 1

Mean (SE) concentration of indivdual cytokines or mediators in the two patient groups at each outpatient visit

Chronic obstructive bronchitisBronchiectasisp Value
Visit 1Visit 2Visit 3Visit 4Visit 1Visit 2Visit 3Visit 4
Myeloperoxidase (units/ml)0.28  (0.03)0.27  (0.03)0.22  (0.04)0.33  (0.04)31.48  (6.98)28.24  (10.53)18.28  (6.46)27.74  (13.33)<0.01
Total elastase (μM)0.032 (0.007)0.034 (0.008)0.033 (0.009)0.033 (0.009)3.62 (1.12)1.93 (0.81)1.59 (0.58)4.66 (1.70)<0.0001
Interleukin 8 (nm)6.05 (1.17)4.02 (0.82)5.95 (2.08)5.00 (2.08)23.36 (4.36)23.72 (3.72)20.75 (4.72)28.00 (4.55)<0.01
LTB4 (nm)11.37 (3.50)6.05 (1.67)10.61 (3.06)9.90 (4.62)25.20 (5.93)25.64 (4.94)27.55 (8.80)23.91 (8.45)0.05
Elastase activity (μm)0000 1.70 (0.65)1.06 (0.46)1.70 (0.71)1.50 (0.50<0.001
Cathepsin B activity (units/ml)00001.49 (0.27)0.76 (0.23)0.72 (0.25)0.79 (0.22)<0.001
SLPI (μm)2.92 (0.52)3.39 (0.80)3.23 (0.93)2.86 (0.70)1.13 (0.36)2.01 (0.62)1.18 (0.24)1.28 (0.45)<0.01
Sputum α1-AT (μm)0.32 (0.04)0.25 (0.04)0.43 (0.06)0.47 (0.05)0.92 (0.03)0.87 (0.04)1.09 (0.05)1.35 (0.09)<0.003
  • LTB4 = leukotriene B4; SLPI = secretory leucocyte proteinase inhibitor; α1-AT = α1-antitrypsin.

  • The lowest significance of any difference between group data is shown and was consistent for each collection point.